Urinary biomarker N-acetyl-β-D-glucosaminidase can predict severity of renal damage in diabetic nephropathy
- PMID: 25717442
- PMCID: PMC4340101
- DOI: 10.1186/s40200-015-0133-6
Urinary biomarker N-acetyl-β-D-glucosaminidase can predict severity of renal damage in diabetic nephropathy
Abstract
Background: Diabetic nephropathy is a clinical diagnosis where proteinuria is present in a patient with diabetes. Early intervention can significantly improve the prognosis. However, imprecision of the currently available biomarkers have impaired effective therapies in a timely manner. Urinary N-acetyl-β-D-glucosaminidase (NAG) is excreted in abnormally high amounts in many renal diseases. The aim of this study was to evaluate urinary NAG as an early biomarker in detection of diabetic nephropathy and whether it parallels the severity of kidney damage in different stages of diabetic nephropathy.
Methods: Fifty patients with type 2 DM were classified into 3 groups (normoalbuminurea, microalbuminurea and macroalbuminurea) and 10 healthy subjects served as a control group. Urinary NAG, albumin and creatinine were measured. Blood urea, serum creatinine, serum albumin, total proteins, serum cholesterol, alanine aminotransferase (ALT), aspartate aminotransferase (AST), fasting and postprandial blood glucose, HbA1c and creatinine clearance were measured for all subjects.
Results: All diabetic patients had a significantly higher level of urinary NAG compared to control. NAG value increased in parallel with the severity of renal involvement.
Conclusion: Urinary NAG expresses the degree of renal impairment in diabetic nephropathy.
Keywords: Albuminurea; Diabetic nephropathy; NAG.
Figures
Similar articles
-
Urinary N-acetyl B glucosaminidase as an earlier marker of diabetic nephropathy and influence of low-dose perindopril/indapamide combination.Ren Fail. 2006;28(2):125-8. doi: 10.1080/08860220500530510. Ren Fail. 2006. PMID: 16538969
-
[Clinical evaluation of N-acetyl-beta-D-glucosaminidase on prediction of diabetic nephropathy].Hokkaido Igaku Zasshi. 1992 Mar;67(2):234-46. Hokkaido Igaku Zasshi. 1992. PMID: 1350771 Japanese.
-
Urinary N-acetyl-beta-d-glucosaminidase levels in diabetic adults.J Lab Physicians. 2019 Jan-Mar;11(1):1-4. doi: 10.4103/JLP.JLP_164_17. J Lab Physicians. 2019. PMID: 30983794 Free PMC article. Review.
-
The renal tubular damage marker urinary N-acetyl-β-D-glucosaminidase may be more closely associated with early detection of atherosclerosis than the glomerular damage marker albuminuria in patients with type 2 diabetes.Cardiovasc Diabetol. 2017 Jan 26;16(1):16. doi: 10.1186/s12933-017-0497-7. Cardiovasc Diabetol. 2017. PMID: 28122570 Free PMC article.
-
Revisiting the Role of NAG across the Continuum of Kidney Disease.Bioengineering (Basel). 2023 Apr 4;10(4):444. doi: 10.3390/bioengineering10040444. Bioengineering (Basel). 2023. PMID: 37106631 Free PMC article. Review.
Cited by
-
Pathomechanisms of Diabetic Kidney Disease.J Clin Med. 2023 Nov 27;12(23):7349. doi: 10.3390/jcm12237349. J Clin Med. 2023. PMID: 38068400 Free PMC article. Review.
-
Association between continuous glucose monitoring-derived glycemic control indices and urinary biomarkers of diabetic kidney disease: Hyogo Diabetes Hypoglycemia Cognition Complications study.Acta Diabetol. 2023 Nov 25. doi: 10.1007/s00592-023-02214-9. Online ahead of print. Acta Diabetol. 2023. PMID: 38006524
-
Evaluation of N-acetyl-β-D-glucosaminidase as a prognostic marker for diabetic nephropathy in type 2 diabetics: systematic review and meta-analysis.Int Urol Nephrol. 2023 Oct 29. doi: 10.1007/s11255-023-03843-3. Online ahead of print. Int Urol Nephrol. 2023. PMID: 37898960 Review.
-
Feasibility of an implantable bioreactor for renal cell therapy using silicon nanopore membranes.Nat Commun. 2023 Aug 29;14(1):4890. doi: 10.1038/s41467-023-39888-2. Nat Commun. 2023. PMID: 37644033 Free PMC article.
-
Liquid Biopsy at the Frontier of Kidney Diseases: Application of Exosomes in Diagnostics and Therapeutics.Genes (Basel). 2023 Jun 28;14(7):1367. doi: 10.3390/genes14071367. Genes (Basel). 2023. PMID: 37510273 Free PMC article. Review.
References
-
- Pedersen MM, Christiansen JS, Pedersen EB, Mogensen CE. Determinants of intra-individual variation in kidney function in normoalbuminuric insulin-dependent diabetic patients: importance of atrial natriuretic peptide and glycaemic control. Clin Sci. 1992;83:445–51. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
